We conduct research and development of products related to RNA/DNA and proteins
Our group conducts research and development of a diverse range of products that target RNA, DNA and proteins based on the technologies developed by Wako's Life Science Research Laboratories to extract nucleic acids, produce antibodies and detect emissions.
Every effort is being made to develop products acknowledged worldwide that address user needs in it being easier to use than the current products, lower in price, and in being highly original.
Research and development efforts for original products
Wako was the first in the world to develop and commercialize the “microRNA Isolation Kit, Human AGO2.”
One example of an original product developed targeting RNA is a product related to microRNAs.
MicroRNAs are a type of small non-coding RNA molecules that do not code proteins, and are being vigorously researched in various fields such as development, cell differentiation, and study of diseases.
In research related to cancer, microRNAs whose amounts vary specifically in association of malignant transformation have been frequently observed, and those microRNAs draw attention worldwide as targets for therapeutics and diagnostics.
We focused on the AGO subfamily proteins that are bound to microRNAs. We believe an affinity purification method that utilizes antibodies specifically recognizing the proteins can be used to purify and concentrate microRNAs. We began commercialization of specific antibodies for each protein in the AGO subfamily. Furthermore, using these antibodies we were the first in the world to commercialize a kit that enable easy extraction of high-purity microRNAs from cells or blood samples.
Again, we have successfully developed original products such as a kit based on our proprietary principle to extract high yields from small amounts of DNA, or our highly efficient DNA methylation detection kit which is based on our proprietary efficient bisulphite method. All these products are highly evaluated by scientists worldwide.
Making products acknowledged worldwide
The criteria for a “good reagent” that our R&D is producing is something that will continue to gain the trust of the users. And that it has proprietary characteristics not possessed by other companies.
Our foremost priority is to make products acknowledged worldwide. Wako would like the world to know about not only the "high-grade reagents" that we have cultivated, but also about our work involving life sciences.
Going forward, we hope to provide products acknowledged by the world in fields such as exosomes known as circulating microvesicles containing RNAs and proteins, or in the epigenetics which is being widely researched in fields such as regenerative medicine and cancer research.
“It is our hope to be of service to future science through the rewarding product development work we enjoy as a team.”
The criteria for a "good reagent" that our R&D is producing is something that will continue to gain the trust of the users. And that it has proprietary characteristics not possessed by other companies. Supply at low prices is also an important point. In order to meet these criteria, we work very closely together with the marketing department specializing in identifying user needs and the product development department which is our product development partner.
Developing reagents involves various research fields which presents us with many opportunities to meet scientists from each of those fields.
The highlights of this work are the many opportunities and stimulation to learn about a diverse range of cutting-edge fields that would otherwise not have been available.
As we enjoy such benefits as a team, we hope to release many reagents that the world will acknowledge.
It is our hope to be of service to future science through the rewarding product development work we enjoy as a team.